Skip to main content

Cue Biopharma, Inc.

CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001645460

In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Cue Biopharma, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CUE: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders7875−3
Shares13.8M14.0M+165.0K (+1.2%)
Value$50.5M$32.1M−$18.4M (−36.4%)

New holders (10)

Institutions that held Cue Biopharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CUE in Q3 2023
InstitutionSharesValue% of portfolio
XTX Topco Ltd53,270$122.5K0.02%
AQR Capital Management LLC23,877$54.9K0.00%
Simplex Trading, LLC22,317$51.0K0.00%
Squarepoint Ops LLC18,903$43.5K0.00%
Wedmont Private Capital20,000$40.8K0.00%
Caption Management, LLC14,000$32.2K0.00%
Wolverine Trading, LLC11,128$25.6K0.00%
Group One Trading, L.P.5,278$12.1K0.00%
Deutsche Bank AG2,349$5.40K0.00%
Russell Investments Group, Ltd.121$2780.00%

Sold out (13)

Institutions that held Cue Biopharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CUE in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Silverarc Capital Management, LLC403,402$1.47M
Jump Financial, LLC42,900$156.6K
Occudo Quantitative Strategies LP37,762$137.8K
D. E. Shaw & Co., Inc.36,681$133.9K
Two Sigma Advisers, LP27,100$98.9K
Mirae Asset Global Investments Co., Ltd.21,036$76.8K
Verition Fund Management LLC21,001$76.7K
MetLife Investment Management18,510$67.6K
Gsa Capital Partners LLP18,269$67.0K
Virtu Financial LLC17,594$64.0K
Two Sigma Investments, LP14,076$51.4K
Algert Global LLC13,230$48.3K
Metropolitan Life Insurance Co1,918$7.00K